Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists

被引:84
作者
Müller, CE
Geis, U
Hipp, J
Schobert, U
Frobenius, W
Pawlowski, M
Suzuki, F
Sandoval-Ramírez, J
机构
[1] Univ Wurzburg, Inst Pharm & Lebensmittelchem, D-97074 Wurzburg, Germany
[2] Kyowa Hakko Kogyo Co Ltd, Pharmaceut Res Labs, Shizuoka 411, Japan
关键词
D O I
10.1021/jm970515+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 8-substituted derivatives of 3,7-dimethyl-1-propargylxanthine (DMPX) was synthesized and investigated as A(2A) adenosine receptor antagonists. Different synthetic strategies for the preparation of DMPX derivatives and analogues were explored. A recently developed synthetic procedure starting from 3-propargyl-5,6-diaminouracil proved to be the method of choice for the preparation of this type of xanthine derivatives. The novel compounds were investigated in radioligand binding studies at the high-affinity adenosine receptor subtypes A(1) and A(2A) and compared with standard A(2A) adenosine receptor antagonists. Structure-activity relationships were analyzed in detail. 8-Styryl-substituted DMPX derivatives were identified that exhibit high affinity and selectivity for A(2A) adenosine receptors, including 8-(m-chlorostyryl)-DMPX (CS-DMPX, K-i A(2A) = 13 nM, 100-fold selective), 8-(m-bromostyryl)-DMPX (BS-DMPX, K-i A(2A) = 8 nM, 146-fold selective), and 8-(3,4-dimethoxystyryl)-DMPX (K-i A(2A) = 15 nM, 167-fold selective). These and other novel compounds are superior to the standard A(2A) adenosine receptor antagonists KF17837 (4) and CSC (5) with respect to A(2A) affinity and/or selectivity.
引用
收藏
页码:4396 / 4405
页数:10
相关论文
共 57 条
[1]  
ALI H, 1991, J PHARMACOL EXP THER, V258, P954
[2]   SYNTHESIS OF NEW PYRAZOLO[4,3-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE AND 1,2,3-TRIAZOLO[4,5-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE DISPLAYING POTENT AND SELECTIVE ACTIVITY AS A(2A) ADENOSINE RECEPTOR ANTAGONISTS [J].
BARALDI, PG ;
MANFREDINI, S ;
SIMONI, D ;
ZAPPATERRA, L ;
ZOCCHI, C ;
DIONISOTTI, S ;
ONGINI, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (21) :2539-2544
[3]   Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: Potent and selective A(2A) adenosine antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Spalluto, G ;
Villatoro, MJPDIY ;
Zocchi, C ;
Dionisotti, S ;
Ongini, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) :1164-1171
[4]  
Baraldi PG, 1995, CURR MED CHEM, V2, P707
[5]   ADENOSINE RECEPTORS IN BRAIN MEMBRANES - BINDING OF N6-CYCLOHEXYL[H-3]ADENOSINE AND 1,3-DIETHYL-8-[H-3]PHENYLXANTHINE [J].
BRUNS, RF ;
DALY, JW ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09) :5547-5551
[6]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[7]  
BRUNS RF, 1990, PURINES CELLULAR SIG
[8]   TRICYCLIC HETEROAROMATIC SYSTEMS - SYNTHESIS AND A(1) AND A(2A) ADENOSINE BINDING ACTIVITIES OF SOME 1-ARYL-1,4-DIHYDRO-3-METHYL[1]BENZOPYRANO[2,3-C]PYRAZOL-4-ONES, 1-ARYL-4,9-DIHYDRO-3-METHYL-1H-PYRAZOLO[3,4-B]QUINOLIN-4-ONES, AND 1-ARYL-1H-IMIDAZO[4,5-B]QUINOXALINES [J].
CATARZI, D ;
CECCHI, L ;
COLOTTA, V ;
FILACCHIONI, G ;
MARTINI, C ;
TACCHI, P ;
LUCACCHINI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (08) :1330-1336
[9]  
Catarzi D., 1992, PHARM PHARM LETT, V2, P74
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099